Oxidative stress and nuclear factor-κB activation: A reassessment of the evidence in the light of recent discoveries

Biochemical Pharmacology

Volumn 59, Issue 1, 2000, Pages 13-23

  Bowie, Andrew ^a   O'Neill, Luke A J ^a  

^a TRINITY COLLEGE DUBLIN   (Ireland)

Author keywords

Antioxidants; Interleukin 1; NF B; Oxidative stress; Signal transduction; Tumour necrosis factor

Indexed keywords

ANTIOXIDANT; HYDROGEN PEROXIDE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1; TRANSCRIPTION FACTOR; TUMOR NECROSIS FACTOR;

ANIMAL CELL; CELL SPECIFICITY; CELL TYPE; HUMAN; HUMAN CELL; LIPID PEROXIDATION; NONHUMAN; OXIDATION REDUCTION REACTION; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN PHOSPHORYLATION; REVIEW; SIGNAL TRANSDUCTION;

EID: 0033990345     PISSN: 00062952     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-2952(99)00296-8     Document Type: Conference Paper

References (97)

1. Sha W.C. Regulation of immune responses by NF-kappa B/Rel transcription factors. J Exp Med. 187:1998;143-146.
2. Baeuerle P.A., Henkel T. Function and activation of NF-kappa B in the immune system. Annu Rev Immunol. 12:1994;141-179.
3. Baeuerle P.A., Baltimore D. NF-kappa B Ten years after . Cell. 87:1996;13-20.
4. O'Neill L.A., Kaltschmidt C. NF-kappa B A crucial transcription factor for glial and neuronal cell function . Trends Neurosci. 20:1997;252-258.
5. Pahl H.L., Baeuerle P.A. A novel signal transduction pathway from the endoplasmic reticulum to the nucleus is mediated by transcription factor NF-kappa B. EMBO J. 14:1995;2580-2588.
6. Shen Y., Rattan V., Sultana C., Kalra V.K. Cigarette smoke condensate-induced adhesion molecule expression and transendothelial migration of monocytes. Am J Physiol. 270:1996;H1624-H1633.
7. Janssen Y.M., Barchowsky A., Treadwell M., Driscoll K.E., Mossman B.T. Asbestos induces nuclear factor kappa B (NF-kappa B) DNA-binding activity and NF-kappa B-dependent gene expression in tracheal epithelial cells. Proc Natl Acad Sci U S A. 92:1995;8458-8462.
8. Whiteside S.T., Israel A. I kappa B proteins Structure, function and regulation . Semin Cancer Biol. 8:1997;75-82.
9. Yaron A., Hatzubai A., Davis M., Lavon I., Amit S., Manning A.M., Andersen J.S., Mann M., Mercurio F., Ben-Neriah Y. Identification of the receptor component of the IkappaBalpha-ubiquitin ligase. Nature. 396:1998;590-594.
10. Stancovski I., Baltimore D. NF-kappaB activation The I kappaB kinase revealed? Cell. 91:1997;299-302.
11. Regnier C.H., Song H.Y., Gao X., Goeddel D.V., Cao Z., Rothe M. Identification and characterization of an IkappaB kinase. Cell. 90:1997;373-383.
12. Mercurio F., Zhu H., Murray B.W., Shevchenko A., Bennett B.L., Li J., Young D.B., Barbosa M., Mann M., Manning A., Rao A. IKK-1 and IKK-2 Cytokine-activated IkappaB kinases essential for NF-kappaB activation . Science. 278:1997;860-866.
13. Woronicz J.D., Gao X., Cao Z., Rothe M., Goeddel D.V. IkappaB kinase-beta NF-kappaB activation and complex formation with IkappaB kinase-alpha and NIK . Science. 278:1997;866-869.
14. DiDonato J.A., Hayakawa M., Rothwarf D.M., Zandi E., Karin M. A cytokine-responsive IkappaB kinase that activates the transcription factor NF-kappaB. Nature. 388:1997;548-554.
15. Zandi E., Rothwarf D.M., Delhase M., Hayakawa M., Karin M. The IkappaB kinase complex (IKK) contains two kinase subunits, IKKalpha and IKKbeta, necessary for IkappaB phosphorylation and NF-kappaB activation. Cell. 91:1997;243-252.
16. Yamaoka S., Courtois G., Bessia C., Whiteside S.T., Weil R., Agou F., Kirk H.E., Kay R.J., Israel A. Complementation cloning of NEMO, a component of the IkappaB kinase complex essential for NF-kappaB activation. Cell. 93:1998;1231-1240.
17. Cohen L., Henzel W.J., Baeuerle P.A. IKAP is a scaffold protein of the IkappaB kinase complex. Nature. 395:1998;292-296.
18. Rothwarf D.M., Zandi E., Natoli G., Karin M. IKK-γ is an essential regulatory subunit of the IκB kinase complex. Nature. 395:1998;297-301.
19. Whiteside S.T., Epinat J.C., Rice N.R., Israel A. I kappa B epsilon, a novel member of the I kappa B family, controls RelA and cRel NF-kappa B activity. EMBO J. 16:1997;1413-1426.
20. Ling L., Cao Z., Goeddel D.V. NF-kappaB-inducing kinase activates IKK-alpha by phosphorylation of Ser-176. Proc Natl Acad Sci USA. 95:1998;3792-3797.
21. Nakano H., Shindo M., Sakon S., Nishinaka S., Mihara M., Yagita H., Okumura K. Differential regulation of IkappaB kinase alpha and beta by two upstream kinases, NF-kappaB-inducing kinase and mitogen-activated protein kinase/ERK kinase kinase-1. Proc Natl Acad Sci USA. 95:1998;3537-3542.
22. Lee F.S., Hagler J., Chen Z.J., Maniatis T. Activation of the IkappaB alpha kinase complex by MEKK1, a kinase of the JNK pathway. Cell. 88:1997;213-222.
23. Karin M., Delhase M. JNK or IKK, AP-1 or NF-kappaB, which are the targets for MEK kinase 1 action? Proc Natl Acad Sci USA. 95:1998;9067-9069.
24. Sakurai H., Miyoshi H., Toriumi W., Sugita T. Functional interactions of transforming growth factor beta-activated kinase 1 with IkappaB kinases to stimulate NF-kappaB activation. J Biol Chem. 274:1999;10641-10648.
25. Ninomiya-Tsuji J., Kishimoto K., Hiyama A., Inoue J., Cao Z., Matsumoto K. The kinase TAK1 can activate the NIK-I kappaB as well as the MAP kinase cascade in the IL-1 signalling pathway. Nature. 398:1999;252-256.
26. Lallena M.J., Diaz-Meco M.T., Bren G., Paya C.V., Moscat J. Activation of IkappaB kinase beta by protein kinase C isoforms. Mol Cell Biol. 19:1999;2180-2188.
27. Zhao Q., Lee F.S. Mitogen-activated protein kinase/ERK kinase kinases 2 and 3 activate nuclear factor-κB through IκB kinase-α and IκB kinase-β J Biol Chem. 274:1999;8355-8358.
28. Schouten G.J., Vertegaal A.C., Whiteside S.T., Israel A., Toebes M., Dorsman J.C., van der Eb A.J., Zantema A. IkappaB alpha is a target for the mitogen-activated 90 kDa ribosomal S6 kinase. EMBO J. 16:1997;3133-3144.
29. Belich M.P., Salmeron A., Johnston L.H., Ley S.C. TPL-2 kinase regulates the proteolysis of the NF-kappaB-inhibitory protein NF-kappaB1 p105. Nature. 397:1999;363-368.
30. Schreck R., Meier B., Mannel D.N., Droge W., Baeuerle P.A. Dithiocarbamates as potent inhibitors of nuclear factor kappa B activation in intact cells. J Exp Med. 175:1992;1181-1194.
31. Schreck R., Rieber P., Baeuerle P.A. Reactive oxygen intermediates as apparently widely used messengers in the activation of the NF-kappa B transcription factor and HIV-1. EMBO J. 10:1991;2247-2258.
32. 2 and antioxidants have opposite effects on activation of NF-kappa B and AP-1 in intact cells AP-1 as secondary antioxidant-responsive factor . EMBO J. 12:1993;2005-2015.
33. Schreck R., Meier B., Mannel D.N., Droge W., Baeuerle P.A. Dithiocarbamates as potent inhibitors of nuclear factor kappa B activation in intact cells. J Exp Med. 175:1992;1181-1194.
34. Schmidt K.N., Amstad P., Cerutti P., Baeuerle P.A. The roles of hydrogen peroxide and superoxide as messengers in the activation of transcription factor NF-kappa B. Chem Biol. 2:1995;13-22.
35. Los M., Schenk H., Hexel K., Baeuerle P.A., Droge W., Schulze-Osthoff K. IL-2 gene expression and NF-kappa B activation through CD28 requires reactive oxygen production by 5-lipoxygenase. EMBO J. 14:1995;3731-3740.
36. Manna S.K., Zhang H.J., Yan T., Oberley L.W., Aggarwal B.B. Overexpression of manganese superoxide dismutase suppresses tumor necrosis factor-induced apoptosis and activation of nuclear transcription factor-kappaB and activated protein-1. J Biol Chem. 273:1998;13245-13254.
37. Brigelius-Flohe R., Friedrichs B., Maurer S., Schultz M., Streicher R. Interleukin-1-induced nuclear factor kappa B activation is inhibited by overexpression of phospholipid hydroperoxide glutathione peroxidase in a human endothelial cell line. Biochem J. 328:1997;199-203.
38. Bonizzi G., Piette J., Schoonbroodt S., Greimers R., Havard L., Merville M.P., Bours V. Reactive oxygen intermediate-dependent NF-kappaB activation by interleukin-1beta requires 5-lipoxygenase or NADPH oxidase activity. Mol Cell Biol. 19:1999;1950-1960.
39. O'Connell M.A., Bennett B.L., Mercurio F., Manning A.M., Mackman N. Role of IKK1 and IKK2 in lipopolysaccharide signaling in human monocytic cells. J Biol Chem. 273:1998;30410-30414.
40. Harhaj E.W., Sun S.C. IkappaB kinases serve as a target of CD28 signaling. J Biol Chem. 273:1998;25185-25190.
41. Ziegler-Heitbrock H.W., Sternsdorf T., Liese J., Belohradsky B., Weber C., Wedel A., Schreck R., Baeuerle P., Strobel M. Pyrrolidine dithiocarbamate inhibits NF-kappa B mobilization and TNF production in human monocytes. J Immunol. 151:1993;6986-6993.
42. Legrand-Poels S., Maniglia S., Boelaert J.R., Piette J. Activation of the transcription factor NF-kappaB in lipopolysaccharide-stimulated U937 cells. Biochem Pharmacol. 53:1997;339-346.
43. Baeuerle P.A. Pro-inflammatory signaling last pieces in the NF-kappaB puzzle? Curr Biol. 8:1998;R19-R22.
44. Roederer M., Staal F.J., Raju P.A., Ela S.W., Herzenberg L.A. Cytokine-stimulated human immunodeficiency virus replication is inhibited by N-acetyl-L-cysteine. Proc Natl Acad Sci USA. 87:1990;4884-4888.
45. Staal F.J., Roederer M., Herzenberg L.A. Intracellular thiols regulate activation of nuclear factor kappa B and transcription of human immunodeficiency virus. Proc Natl Acad Sci USA. 87:1990;9943-9947.
46. Toledano M.B., Leonard W.J. Modulation of transcription factor NF-kappa B binding activity by oxidation-reduction in vitro. Proc Natl Acad Sci USA. 88:1991;4328-4332.
47. Matthews J.R., Watson E., Buckley S., Hay R.T. Interaction of the C-terminal region of p105 with the nuclear localisation signal of p50 is required for inhibition of NF-kappa B DNA binding activity. Nucleic Acids Res. 21:1993;4516-4523.
48. Matthews J.R., Wakasugi N., Virelizier J.L., Yodoi J., Hay R.T. Thioredoxin regulates the DNA binding activity of NF-kappa B by reduction of a disulphide bond involving cysteine 62. Nucleic Acids Res. 20:1992;3821-3830.
49. Droge W., Schulze-Osthoff K., Mihm S., Galter D., Schenk H., Eck H.P., Roth S., Gmunder H. Functions of glutathione and glutathione disulfide in immunology and immunopathology. FASEB J. 8:1994;1131-1138.
50. Schreck R., Baeuerle P.A. Assessing oxygen radicals as mediators in activation of inducible eukaryotic transcription factor NF-kappa B. Methods Enzymol. 234:1994;151-163.
51. Israel N., Gougerot-Pocidalo M.A., Aillet F., Virelizier J.L. Redox status of cells influences constitutive or induced NF-kappa B translocation and HIV long terminal repeat activity in human T and monocytic cell lines. J Immunol. 149:1992;3386-3393.
52. Moynagh P.N., Williams D.C., O'Neill L.A. Activation of NF-kappa B and induction of vascular cell adhesion molecule-1 and intracellular adhesion molecule-1 expression in human glial cells by IL-1. Modulation by antioxidants. J Immunol. 153:1994;2681-2690.
53. Anderson M.T., Staal F.J., Gitler C., Herzenberg L.A. Separation of oxidant-initiated and redox-regulated steps in the NF-kappa B signal transduction pathway. Proc Natl Acad Sci USA. 91:1994;11527-11531.
54. Brennan P., O'Neill L.A. Effects of oxidants and antioxidants on nuclear factor kappa B activation in three different cell lines Evidence against a universal hypothesis involving oxygen radicals . Biochim Biophys Acta. 1260:1995;167-175.
55. Bradley J.R., Johnson D.R., Pober J.S. Endothelial activation by hydrogen peroxide. Selective increases of intercellular adhesion molecule-1 and major histocompatibility complex class I. Am J Pathol. 142:1993;1598-1609.
56. 2 in NF-kappaB activation by either cytokine in both primary and transformed endothelial cells. J Biol Chem. 272:1997;25941-25950.
57. Schieven G.L., Kirihara J.M., Myers D.E., Ledbetter J.A., Uckun F.M. Reactive oxygen intermediates activate NF-kappa B in a tyrosine kinase-dependent mechanism and in combination with vanadate activate the p56lck and p59fyn tyrosine kinases in human lymphocytes. Blood. 82:1993;1212-1220.
58. Legrand-Poels S., Bours V., Piret B., Pflaum M., Epe B., Rentier B., Piette J. Transcription factor NF-kappa B is activated by photosensitization generating oxidative DNA damage. J Biol Chem. 270:1995;6925-6934.
59. Bonizzi G., Dejardin E., Piret B., Piette J., Merville M.P., Bours V. Interleukin-1 beta induces nuclear factor kappa B in epithelial cells independently of the production of reactive oxygen intermediates. Eur J Biochem. 242:1996;544-549.
60. Schoonbroodt S., Legrand-Poels S., Best-Belpomme M., Piette J. Activation of the NF-kappaB transcription factor in a T-lymphocytic cell line by hypochlorous acid. Biochem J. 321:(Pt 3):1997;777-785.
61. 2 for platelet-derived growth factor signal transduction. Science. 270:1995;296-299.
62. 2 . Role in cell survival following oxidant injury. J Biol Chem. 271:1996;4138-4142.
63. Verheij M., Bose R., Lin X.H., Yao B., Jarvis W.D., Grant S., Birrer M.J., Szabo E., Zon L.I., Kyriakis J.M., Haimovitz-Friedman A., Fuks Z., Kolesnick R.N. Requirement for ceramide-initiated SAPK/JNK signalling in stress-induced apoptosis. Nature. 380:1996;75-79.
64. Sundaresan M., Yu Z.X., Ferrans V.J., Sulciner D.J., Gutkind J.S., Irani K., Goldschmidt-Clermont P.J., Finkel T. Regulation of reactive-oxygen-species generation in fibroblasts by Rac1. Biochem J. 318:1996;379-382.
65. Irani K., Xia Y., Zweier J.L., Sollott S.J., Der C.J., Fearon E.R., Sundaresan M., Finkel T., Goldschmidt-Clermont P.J. Mitogenic signaling mediated by oxidants in Ras-transformed fibroblasts. Science. 275:1997;1649-1652.
66. 2+ in oxidant-induced NF-kappa B activation. FEBS Lett. 385:1996;58-62.
67. Galter D., Mihm S., Droge W. Distinct effects of glutathione disulphide on the nuclear transcription factor kappa B and the activator protein-1. Eur J Biochem. 221:1994;639-648.
68. Boland M.P., Foster S.J., O'Neill L.A. Daunorubicin activates NFkappaB and induces kappaB-dependent gene expression in HL-60 promyelocytic and Jurkat T lymphoma cells. J Biol Chem. 272:1997;12952-12960.
69. Imbert V., Rupec R.A., Livolsi A., Pahl H.L., Traenckner E.B., Mueller-Dieckmann C., Farahifar D., Rossi B., Auberger P., Baeuerle P.A., Peyron J.F. Tyrosine phosphorylation of I kappa B-alpha activates NF-kappa B without proteolytic degradation of I kappa B-alpha. Cell. 86:1996;787-798.
70. Beraud C., Henzel W.J., Baeuerle P.A. Involvement of regulatory and catalytic subunits of phosphoinositide 3-kinase in NF-kappaB activation. Proc Natl Acad Sci USA. 96:1999;429-434.
71. Roberts M.L., Cowsert L.M. Interleukin-1 beta and reactive oxygen species mediate activation of c-Jun NH2-terminal kinases, in human epithelial cells, by two independent pathways. Biochem Biophys Res Commun. 251:1998;166-172.
72. Flohe L., Brigelius-Flohe R., Saliou C., Traber M.G., Packer L. Redox regulation of NF-kappa B activation. Free Radic Biol Med. 22:1997;1115-1126.
73. Chen Z.J., Parent L., Maniatis T. Site-specific phosphorylation of IkappaBalpha by a novel ubiquitination-dependent protein kinase activity. Cell. 84:1996;853-862.
74. Meier B., Radeke H.H., Selle S., Younes M., Sies H., Resch K., Habermehl G.G. Human fibroblasts release reactive oxygen species in response to interleukin-1 or tumour necrosis factor-alpha. Biochem J. 263:1989;539-545.
75. O'Donnell V.B., Spycher S., Azzi A. Involvement of oxidants and oxidant-generating enzyme(s) in tumour-necrosis-factor-alpha-mediated apoptosis Role for lipoxygenase pathway but not mitochondrial respiratory chain . Biochem J. 310:(Pt 1):1995;133-141.
76. Royall J.A., Gwin P.D., Parks D.A., Freeman B.A. Responses of vascular endothelial oxidant metabolism to lipopolysaccharide and tumor necrosis factor-alpha. Arch Biochem Biophys. 294:1992;686-694.
77. Suzuki Y.J., Packer L. Inhibition of NF-kappa B DNA binding activity by alpha-tocopheryl succinate. Biochem Mol Biol Int. 31:1993;693-700.
78. Suzuki Y.J., Aggarwal B.B., Packer L. Alpha-lipoic acid is a potent inhibitor of NF-kappa B activation in human T cells. Biochem Biophys Res Commun. 189:1992;1709-1715.
79. Aruoma O.I., Halliwell B., Hoey B.M., Butler J. The antioxidant action of N-acetylcysteine Its reaction with hydrogen peroxide, hydroxyl radical, superoxide, and hypochlorous acid . Free Radic Biol Med. 6:1989;593-597.
80. Suzuki Y.J., Packer L. Inhibition of NF-kappa B transcription factor by catechol derivatives. Biochem Mol Biol Int. 32:1994;299-305.
81. Sunderman F.W. Sr. Therapeutic properties of sodium diethyldithiocarbamate Its role as an inhibitor in the progression of AIDS . Ann Clin Lab Sci. 21:1991;70-81.
82. Reisinger E.C., Kern P., Ernst M., Bock P., Flad H.D., Dietrich M. Inhibition of HIV progression by dithiocarb. German DTC Study Group. Lancet. 335:1990;679-682.
83. Topping R.J., Jones M.M. Optimal dithiocarbamate structure for immunomodulator action. Med Hypotheses. 27:1988;55-57.
84. Satriano J., Schlondorff D. Activation and attenuation of transcription factor NF-kB in mouse glomerular mesangial cells in response to tumor necrosis factor-alpha, immunoglobulin G, and adenosine 3′:5′-cyclic monophosphate. Evidence for involvement of reactive oxygen species. J Clin Invest. 94:1994;1629-1636.
85. Kawai M., Nishikomori R., Jung E.Y., Tai G., Yamanaka C., Mayumi M., Heike T. Pyrrolidine dithiocarbamate inhibits intercellular adhesion molecule-1 biosynthesis induced by cytokines in human fibroblasts. J Immunol. 154:1995;2333-2341.
86. Schmidt K.N., Podda M., Packer L., Baeuerle P.A. Anti-psoriatic drug anthralin activates transcription factor NF-kappa B in murine keratinocytes. J Immunol. 156:1996;4514-4519.
87. Nobel C.I., Kimland M., Lind B., Orrenius S., Slater A.F. Dithiocarbamates induce apoptosis in thymocytes by raising the intracellular level of redox-active copper. J Biol Chem. 270:1995;26202-26208.
88. Brennan P., O'Neill L.A. 2-Mercaptoethanol restores the ability of nuclear factor kappa B (NF kappa B) to bind DNA in nuclear extracts from interleukin 1-treated cells incubated with pyrollidine dithiocarbamate (PDTC). Evidence for oxidation of glutathione in the mechanism of inhibition of NF kappa B by PDTC. Biochem J. 320:(Pt 3):1996;975-981.
89. Mihm S., Galter D., Droge W. Modulation of transcription factor NF kappa B activity by intracellular glutathione levels and by variations of the extracellular cysteine supply. FASEB J. 9:1995;246-252.
90. Courtois G., Whiteside S.T., Sibley C.H., Israel A. Characterization of a mutant cell line that does not activate NF-kappaB in response to multiple stimuli. Mol Cell Biol. 17:1997;1441-1449.
91. Baumann B., Kistler B., Kirillov A., Bergman Y., Wirth T. The mutant plasmacytoma cell line S107 allows the identification of distinct pathways leading to NF-kappaB activation. J Biol Chem. 273:1998;11448-11455.
92. Mahon T.M., O'Neill L.A. Studies into the effect of the tyrosine kinase inhibitor herbimycin A on NF-kappa B activation in T lymphocytes. Evidence for covalent modification of the p50 subunit. J Biol Chem. 270:1995;28557-28564.
93. Brennan P., O'Neill L.A. Inhibition of nuclear factor kappaB by direct modification in whole cells - Mechanism of action of nordihydroguaiaritic acid, curcumin and thiol modifiers. Biochem Pharmacol. 55:1998;965-973.
94. Schwenger P., Alpert D., Skolnik E.Y., Vilcek J. Activation of p38 mitogen-activated protein kinase by sodium salicylate leads to inhibition of tumour necrosis factor-induced I kappa B alpha phosphorylation and degradation. Mol Cell Biol. 18:1998;78-84.
95. Suzuki Y.J., Mizuno M., Packer L. Transient overexpression of catalase does not inhibit TNF- or PMA-induced NF-kappa B activation. Biochem Biophys Res Commun. 210:1995;537-541.
96. Barradas M.A., Jeremy J.Y., Kontoghiorghes G.J., Mikhailidis D.P., Hoffbrand A.V., Dandona P. Iron chelators inhibit human platelet aggregation, thromboxane A2 synthesis and lipoxygenase activity. FEBS Lett. 245:1989;105-109.
97. Bonizzi G., Piette J., Merville M.P., Bours V. Distinct signal transduction pathways mediate nuclear factor-kappaB induction by IL-1beta in epithelial and lymphoid cells. J Immunol. 159:1997;5264-5272.